Dose Milnacipran Prevent Depressive Symptoms in Patients With Acute Stroke?
Status:
Unknown status
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
Depression is one of the important psychiatric sequelae after stroke. The prevalence of post
stroke depression (PSD) is approximately 20-40%. Depression comorbid with stroke has been
found to be associated with increased disability, cognitive function decline, poorer
rehabilitation outcome and higher mortality rate.We are going to conduct a trial of
prevention of psot stroke depression by prescribing milnacipran in advance.